
HPV Vaccine Credited for Decline in Cervical Cancer Deaths Among Young Women
A recent study published in JAMA Network highlights a significant decline in cervical cancer deaths among women under 25, attributed to the widespread vaccination against human papillomavirus (HPV). Researchers, including Ashish Deshmukh from MUSC's Hollings Cancer Center, emphasize this as a major public health success, crediting the HPV vaccine for the reduction in cancer cases.

